<?xml version="1.0" encoding="utf-8"?>
<feed version="0.3" xmlns="http://purl.org/atom/ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xml:lang="en">
<title>Patent Prospector</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/" />
<modified>2009-07-04T05:42:17Z</modified>
<tagline>An open forum for patent practitioners.</tagline>
<id>tag:www.patenthawk.com,2009:/blog//1</id>
<generator url="http://www.movabletype.org/" version="4.1">Movable Type</generator>
<copyright>Copyright (c) 2009, Patent Hawk</copyright>

<entry>
<title>Gift from the Dead</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/07/gift_from_the_dead.html" />
<modified>2009-07-04T05:42:17Z</modified>
<issued>2009-07-04T05:40:33Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4142</id>
<created>2009-07-04T05:40:33Z</created>
<summary type="text/plain"><![CDATA[ 5,761,645 claims a &quot;system for enabling delivery of insurance gift payments&quot; to beneficiaries. Owner Equitable Life &amp; Casualty Insurance has sued rival American National Insurance over it, as part of an ongoing enforcement campaign. Other insurance companies have been taken to task over '645, and settled. The patent is likely invalid, for mixing claim types (system and method), as well as its obviousness....]]></summary>
<author>
<name>Patent Hawk</name>
<url>http://www.patenthawk.com/</url>
<email>info@patenthawk.com</email>
</author>
<dc:subject>Litigation</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p>
<img border="0" src="http://www.patenthawk.com/blog_images/gdead.jpg" align="right" width="139" height="112"><a href="http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/PTO/srchnum.htm&r=1&f=G&l=50&s1=5,761,645.PN.&OS=PN/5,761,645&RS=PN/5,761,645">5,761,645</a> 
claims a &quot;system 
for enabling delivery of insurance gift payments&quot; to beneficiaries. Owner 
Equitable Life &amp; Casualty Insurance has sued rival American National Insurance 
over it, as part of an ongoing enforcement campaign. Other insurance companies 
have been taken to task over '645, and settled. The patent is likely invalid, 
for mixing claim types (system and method), as well as its obviousness.</p>]]>

</content>
</entry>

<entry>
<title>Cut to Commercial</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/07/cut_to_commercial.html" />
<modified>2009-07-02T08:25:14Z</modified>
<issued>2009-07-02T08:24:02Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4141</id>
<created>2009-07-02T08:24:02Z</created>
<summary type="text/plain"> In years past, big-screen TV buyers gravitated to plasma displays, as LCDs were prohibitively expense for 50+ inch screens. But as LCD screen technology has advanced, plasma sales have receded. In 2008, four million plasma screens were sold in North America, while 30 million LCD TVs found homes. That gap is widening. And so the price of plasma displays is dropping. With market realities in mind, Japan&apos;s Hitachi and Korea&apos;s LG Electronics have settled their plasma patent dispute with a cross-license....</summary>
<author>
<name>Patent Hawk</name>
<url>http://www.patenthawk.com/</url>
<email>info@patenthawk.com</email>
</author>
<dc:subject>Patents In Business</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p>
<img border="0" src="http://www.patenthawk.com/blog_images/plasmagirl.jpg" align="right" width="165" height="183">In 
years past, big-screen TV buyers gravitated to plasma displays, as LCDs were 
prohibitively expense for 50+ inch screens. But as LCD screen technology has 
advanced, plasma sales have receded. In 2008, four million plasma screens were 
sold in North America, while 30 million LCD TVs found homes. That gap is 
widening. And so
<a href="http://online.wsj.com/article/SB10001424052970204556804574259990242827838.html">
the price of plasma displays is dropping</a>. With market realities in mind, 
Japan's Hitachi and Korea's LG Electronics have settled their plasma patent 
dispute with a
<a href="http://online.wsj.com/article/BT-CO-20090702-700246.html">cross-license</a>.</p>]]>

</content>
</entry>

<entry>
<title>Researching</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/07/researching.html" />
<modified>2009-07-02T08:25:37Z</modified>
<issued>2009-07-02T08:05:48Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4140</id>
<created>2009-07-02T08:05:48Z</created>
<summary type="text/plain"> On patent reform, the Senate shoots first and ask questions later. Judiciary Chairman Patrick Leahy hustled his cockamamie patent bill out of committee in April on a 15-4 vote. Now judiciary committee member Jeff Sessions is wondering what impact the proposed post-grant challenge process might have....</summary>
<author>
<name>Patent Hawk</name>
<url>http://www.patenthawk.com/</url>
<email>info@patenthawk.com</email>
</author>
<dc:subject>The Patent System</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p>
<img border="0" src="http://www.patenthawk.com/blog_images/clouded_question_small.gif" align="right" width="54" height="82">On 
patent reform, the Senate shoots first and ask questions later. Judiciary 
Chairman Patrick Leahy hustled his cockamamie patent bill out of committee in 
April on a 15-4 vote. Now judiciary committee member Jeff Sessions is
<a href="http://techdailydose.nationaljournal.com/mt/mt-search.cgi?search=trademark&IncludeBlogs=57">
wondering</a> what impact the proposed post-grant challenge process might have.</p>]]>

</content>
</entry>

<entry>
<title>Fully Fueled</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/07/fully_fueled.html" />
<modified>2009-07-02T07:49:08Z</modified>
<issued>2009-07-02T07:43:13Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4139</id>
<created>2009-07-02T07:43:13Z</created>
<summary type="text/plain"> The hyperactive Obama administration wants efficient cars, hoping to implement fleet fuel economy imperatives that politically ran out of gas forty years ago. The hope for fuel-efficiency lies with hybrids, which cruise on electric power and hit the gas when a driver hits the accelerator. One company has the real impetus: Toyota, which has around 2,100 patents for hybrid vehicles. Number two, Honda, has about half as many hybrid patents in its portfolio. Nissan, relatively hybrid patentless, is puttering with electric cars....</summary>
<author>
<name>Patent Hawk</name>
<url>http://www.patenthawk.com/</url>
<email>info@patenthawk.com</email>
</author>
<dc:subject>Patents In Business</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p>
<img border="0" src="http://www.patenthawk.com/blog_images/prius2.jpg" align="right">The 
hyperactive Obama administration wants efficient cars, hoping to implement fleet 
fuel economy imperatives that politically ran out of gas forty years ago. The 
hope for fuel-efficiency lies with hybrids, which cruise on electric power and 
hit the gas when a driver hits the accelerator. One company has the real 
impetus: Toyota, which has around 2,100 patents for hybrid vehicles. Number two, 
Honda, has about half as many hybrid patents in its portfolio. Nissan, relatively 
hybrid patentless, is puttering with electric cars. </p>]]>
<![CDATA[<p>Toyota has a culture of cooperation that has made it the world's leader in 
automotive technology. Unlike American car makers, which for decades squeezed 
component suppliers for low cost as integral to their strategy of going broke, 
Toyota has cross-holdings with its suppliers, constantly encouraging innovation, 
not mere cost-cutting. </p>
<p>The Toyota way also means that the company has not been 
litigious, preferring quiet licensing deals. Ford has a cross-license with 
Toyota for hybrid technology, where, Ford claims, no money changed hands.</p>
<p>More in the
<a href="http://online.wsj.com/article/SB124640553503576637.html?mod=googlenews_wsj">
Wall Street Journal</a>.</p>]]>
</content>
</entry>

<entry>
<title>B+</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/06/b.html" />
<modified>2009-07-01T08:06:32Z</modified>
<issued>2009-07-01T07:58:11Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4138</id>
<created>2009-07-01T07:58:11Z</created>
<summary type="text/plain"><![CDATA[ Monday, an East Texas jury awarded $1.67 billion for infringing a single patent: 7,070,775, which Centocor and New York University jointly own. '775 claims an &quot;antibody or antigen-binding fragment.&quot; The patent applies to an arthritis drug. Abbott was the infringing party. $1.17 billion was for lost profits, plus $504 million for reasonable royalty damages. Abbott continues to swear non-infringement. The infringing product, Humira, sold more than $4.5 billion in 2008, Abbott's top seller, accounting for 15% of its revenues last year. Centocor's competing arthritis drug is Remicade....]]></summary>
<author>
<name>Patent Hawk</name>
<url>http://www.patenthawk.com/</url>
<email>info@patenthawk.com</email>
</author>
<dc:subject>Damages</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p>
<img border="0" src="http://www.patenthawk.com/blog_images/happy_beachcomber.jpg" align="right" width="183" height="141">Monday, 
an East Texas jury awarded $1.67 billion for infringing a single patent:
<a href="http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/PTO/srchnum.htm&r=1&f=G&l=50&s1=7,070,775.PN.&OS=PN/7,070,775&RS=PN/7,070,775">
7,070,775</a>, which Centocor and New York University jointly own. '775 claims an 
&quot;antibody or antigen-binding fragment.&quot; The patent applies to an arthritis drug. 
Abbott was the infringing party. $1.17 billion was for lost profits, plus $504 
million for reasonable royalty damages. Abbott continues to swear 
non-infringement. The infringing product, <a href="http://www.humira.com/">
Humira</a>, sold more than $4.5 billion in 2008, Abbott's top seller, accounting 
for 15% of its revenues last year. Centocor's competing arthritis drug is
<a href="http://www.remicade.com/remicade/global/index.html">Remicade</a>.</p>]]>

</content>
</entry>

<entry>
<title>Requisite Clarity</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/06/requisite_clarity.html" />
<modified>2009-06-29T17:56:31Z</modified>
<issued>2009-06-29T17:04:17Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4137</id>
<created>2009-06-29T17:04:17Z</created>
<summary type="text/plain"> In Bilski, the rogue CAFC ruled on the wrong grounds, and in the process warped the law, by setting in stone what were intended as guidelines. To afford case-by-case consideration, a court writes itself wiggle room. Instead, the CAFC tends to sew itself straightjackets. To invalidate Bilski&apos;s claim, all SCOTUS need do is reaffirm the definiteness requirement, and then correct the CAFC&apos;s errant way regarding patentable process subject matter....</summary>
<author>
<name>Patent Hawk</name>
<url>http://www.patenthawk.com/</url>
<email>info@patenthawk.com</email>
</author>
<dc:subject>§ 101</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p>
<img border="0" src="http://www.patenthawk.com/blog_images/stonehead.jpg" align="right" width="109" height="105">In
<i><a href="http://www.patenthawk.com/blog/2008/10/method_acting.html">Bilski</a></i>, 
the rogue CAFC ruled on the wrong grounds, and in the process warped the law, by 
setting in stone what were intended as guidelines. To afford case-by-case 
consideration, a court writes itself wiggle room. Instead, the CAFC tends to sew 
itself straightjackets. To invalidate Bilski's claim, all SCOTUS need do is 
reaffirm the definiteness requirement, and then correct the CAFC's errant way 
regarding patentable process subject matter.</p>]]>
<![CDATA[<p>What the Supreme 
Court needs to do with <i>Bilski</i>, reversing the CAFC on two fronts, is 
insist on &quot;claims particularly pointing out and distinctly claiming the subject 
matter which the applicant regards as his invention,&quot; and again clarify the signposts of patentability, 
while removing the blocks that the CAFC had cast in stone. </p>
<p>In <i>Bilski</i>, the CAFC took clues to patentability and rendered them 
exclusive metrics. (&quot;Transformation and reduction of an article 'to a different 
state or thing' is <u>the clue</u> to the patentability of a process claim that 
does not include particular machines.&quot; - <i><a href="http://www.patenthawk.com/blog/2009/06/the_diamond.html">
Diamond v. Diehr</a></i>, 450 U.S. 175 (1981)) The law requires nothing more 
than a &quot;new and useful process,&quot; or its &quot;improvement thereof&quot;. In <i>
<a href="http://www.patenthawk.com/blog/2007/04/obviousness_redux.html">KSR</a></i>, 
the Supreme Court chided the CAFC about its rigidity. Another reminder is in 
order, as old habits die hard. A very long-standing doctrine, Congress and 
SCOTUS have consistently left patentable subject matter open-ended with regard 
to technology, including process claims, whilst rightfully shutting the door to 
&quot;laws of nature, natural phenomena, and abstract ideas.&quot; Patentability needs no 
further circumscription.</p>
<p>On the other hand, the CAFC has been far too lenient in enforcing 
definiteness, practically eviscerating the statute's requirement for clarity. 
From the CAFC in <i><a href="http://www.patenthawk.com/blog/2008/09/tanked.html">Praxair v. 
Advanced Technology Materials</a></i> (2008) -</p>
<blockquote>
	<p>The second paragraph of 35 U.S.C. § 112 requires that the specification 
	of every patent must &quot;conclude with one or more claims particularly pointing 
	out and distinctly claiming the subject matter which the applicant regards 
	as his invention.&quot; This requirement serves a public notice function, 
	ensuring that the patent specification adequately notifies the public of the 
	scope of the patentee's right to exclude. <i>See Honeywell Int'l, Inc. v. 
	Int'l Trade Comm'n</i>, 341 F.3d 1332, 1338 (Fed. Cir. 2003). A claim 
	satisfies the definiteness requirement of § 112 &quot;[i]f one skilled in the art 
	would understand the bounds of the claim when read in light of the 
	specification.&quot; <i>Exxon Research &amp; Eng'g Co. v. United States</i>, 265 F.3d 
	1371, 1375 (Fed. Cir. 2001). <u>A claim will be found indefinite only if it 
	&quot;is insolubly ambiguous, and no narrowing construction can properly be 
	adopted . . . .</u>&quot; <i>Id</i>. On the other hand, &quot;[i]f the meaning of the 
	claim is discernible, even though the task may be formidable and the 
	conclusion may be one over which reasonable persons will disagree, we have 
	held the claim sufficiently clear to avoid invalidity on indefiniteness 
	grounds.&quot; <i>Id</i>.</p>
</blockquote>
<p>Neither the Congress nor the Supreme Court had such laxity in mind. From the 
Supreme Court's <i>
<a href="http://www.law.cornell.edu/supct/html/00-1543.ZO.html">Festo Corp. v. 
Shoketsu Kinzoku Kogyo Kabushiki Co., Ltd</a>.</i> (2002) -</p>
<blockquote>
	<p>The patent laws "promote the Progress of Science and useful Arts" by 
	rewarding innovation with a temporary monopoly. U.S. Const., Art. I, §8, cl. 
	8. The monopoly is a property right; and like any property right, <u>its 
	boundaries should be clear</u>. <u>This clarity is essential to promote 
	progress</u>, because it enables efficient investment in innovation. A 
	patent holder should know what he owns, and the public should know what he 
	does not. <u>For this reason, the patent laws require inventors to describe 
	their work in "full, clear, concise, and exact terms," 35 U.S.C. § 112</u> 
	as part of the delicate balance the law attempts to maintain between 
	inventors, who rely on the promise of the law to bring the invention forth, 
	and the public, which should be encouraged to pursue innovations, creations, 
	and new ideas beyond the inventor's exclusive rights. <i>Bonito Boats, Inc. 
	v. Thunder Craft Boats, Inc</i>., 489 U.S. 141, 150 (1989).</p>
</blockquote>
<p>In its <i>Bilski</i> decision, the Supreme Court needs to right the 
definiteness requirement to &quot;full, clear, concise, and exact terms,&quot; and remind 
&quot;that Congress intended statutory subject matter to 'include anything under the 
sun that is made by man.'&quot;</p>
<p>This is a companion piece to
<a href="http://www.patenthawk.com/blog/2009/06/definitely_not.html">Definitely 
Not</a>.</p>]]>
</content>
</entry>

<entry>
<title>Jackson</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/06/jackson.html" />
<modified>2009-06-27T18:13:27Z</modified>
<issued>2009-06-27T16:57:37Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4136</id>
<created>2009-06-27T16:57:37Z</created>
<summary type="text/plain"><![CDATA[A contribution to the media obsession&nbsp;surrounding the death of the King of Pop: In 1993, Michael Jackson was granted patent 5,255,452 for a "Method and means for creating anti-gravity illusion."&nbsp;Specially designed shoes engaged with hitch members protruding through&nbsp;the stage, allowing the wearer to lean beyond their center of&nbsp;gravity. The illusion was used by Jackson&nbsp;in the music video for Smooth Criminal....]]></summary>
<author>
<name>Mr. Platinum</name>
<url>http://www.patenthawk.com/</url>
<email>jordan@patenthawk.com</email>
</author>
<dc:subject>The Patent System</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p><img border="0" hspace="0" align="right" src="http://www.patenthawk.com/blog_images/jackson_lean2.jpg" width=284 height=151>A contribution to the media 
obsession&nbsp;surrounding the death of the King of Pop: In 1993, Michael 
Jackson was granted patent <a 
href="http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;d=PALL&amp;p=1&amp;u=/netahtml/PTO/srchnum.htm&amp;r=1&amp;f=G&amp;l=50&amp;s1=5255452.PN.&amp;OS=PN/5255452&amp;RS=PN/5255452">5,255,452</a> 
for a "Method and means for creating anti-gravity illusion."&nbsp;Specially 
designed shoes engaged with hitch members protruding through&nbsp;the stage, 
allowing the wearer to lean beyond their center of&nbsp;gravity. The illusion 
was used by Jackson&nbsp;in the <a 
href="http://www.youtube.com/watch?v=2WjOn5TNjBM&amp;feature=fvst">music 
video</a> for Smooth Criminal.</p>]]>

</content>
</entry>

<entry>
<title>Rich-Media Invalidity</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/06/richmedia_invalidity.html" />
<modified>2009-06-27T06:28:16Z</modified>
<issued>2009-06-27T03:40:14Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4135</id>
<created>2009-06-27T03:40:14Z</created>
<summary type="text/plain"> Another junk patent is on the prowl. How Neil Balthaser was allowed 7,000,180, claiming methods for creating and editing rich-media, is beyond rational explanation. There is a ton of prior art invalidating the patent. Balthaser has a four suits in East Texas with a slew of defendants. Network Solutions just settled, terms undisclosed....</summary>
<author>
<name>Patent Hawk</name>
<url>http://www.patenthawk.com/</url>
<email>info@patenthawk.com</email>
</author>
<dc:subject>Litigation</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p>
<img border="0" src="http://www.patenthawk.com/blog_images/rich_media.jpg" align="right">Another 
junk patent is on the prowl. How Neil Balthaser was allowed
<a href="http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/PTO/srchnum.htm&r=1&f=G&l=50&s1=7,000,180.PN.&OS=PN/7,000,180&RS=PN/7,000,180">
7,000,180</a>, claiming methods for creating and editing rich-media, is beyond 
rational explanation. There is a ton of prior art invalidating the patent. 
Balthaser has a four suits in East Texas with a slew of defendants. Network 
Solutions just settled, terms undisclosed.</p>]]>

</content>
</entry>

<entry>
<title>Convenience of Coincidence</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/06/convenience_of_coincidence.html" />
<modified>2009-06-26T22:06:44Z</modified>
<issued>2009-06-26T21:00:24Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4134</id>
<created>2009-06-26T21:00:24Z</created>
<summary type="text/plain"><![CDATA[Decisions made at the UPSTO have ironically spawned an anti-patent culture at the very institute created to protect innovation. These decisions&nbsp;have consequences. Conveniently though, the US economy has tanked, providing the PTO with a thick sheet of smoke to help veil countless managerial missteps. Knowing his role as smoke machine, Acting Director John Doll recently provided a financial update of the patent office, transferring blame and hoping for a bailout....]]></summary>
<author>
<name>Mr. Platinum</name>
<url>http://www.patenthawk.com/</url>
<email>jordan@patenthawk.com</email>
</author>
<dc:subject>The Patent Office</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p><img border="0" hspace="0" align="right" src="http://www.patenthawk.com/blog_images/john_doll_sit.jpg" width="112" height="160">Decisions made at the UPSTO have 
ironically spawned an anti-patent culture at the very institute created to 
protect innovation. These decisions&nbsp;have consequences. Conveniently though, 
the US economy has tanked, providing the PTO with a thick sheet of smoke to help 
veil countless managerial missteps. Knowing his role as smoke machine, Acting 
Director John Doll recently provided a financial update of the patent office, 
transferring blame and hoping for a bailout.</p>]]>
<![CDATA[<p>From the USPTO Broadcast:</p>
<blockquote><p>Back in March, I provided you an update on the budget 
challenges facing our agency. Today, I'd like to let you know where we 
stand and what steps we're taking to address these challenges.</p>
<p>As you know, the USPTO is funded solely by user fees. This 
process means the USPTO develops its budget based on projected fee 
collections. As the economy has worsened, fewer people have applied for 
patents or paid to maintain the ones they have. Declines in 
trademark filings continue to be experienced too. Thus, the agency has 
seen significant reductions in revenue.&nbsp; As a result, a serious budget 
situation has developed.</p><p>Right now, we are operating at a "break 
even" level. This means, if the current pace of fee collection holds, the 
USPTO expects to finish FY09 without a budget shortfall.</p><p>But just 
getting to "break even" in this climate has required sacrifices. In response to 
the decrease in fee collections, we have enacted a series of budget cuts and 
cost-savings measures, which have resulted in more than $120 million in 
savings. Thus far, we have instituted a hiring freeze, curtailed 
non-bargaining unit performance awards, stopped overtime, and significantly 
reduced contracts, travel, supplies and other non-essential overhead 
expenses.&nbsp; These cuts, while necessary, have been difficult, and I want to 
personally thank you for your understanding. </p><p>With the support of 
Commerce Secretary Locke, we are also seeking further cost-saving measures, 
which will save an additional $20 million in FY09. </p><p>All of this has 
been done with an eye toward avoiding furloughs.</p><p>Yet we know that 
in the current economy, fee collection could continue to decline. The USPTO and 
the Department of Commerce are monitoring the situation on a daily basis, and 
out of an abundance of caution, we are asking Congress for its help. We're now 
putting forward a number of different options to bridge any possible gaps, and 
we'll also be soliciting ideas from members of Congress.</p><p>We will 
continue to keep you apprised of any new developments, and I thank you again for 
your support during this challenging time.</p></blockquote>
<p>
     Doll assumes 
no responsibility for declining fee collection. Any idiot can see 
the most likely cause of revenue reduction:&nbsp;decreasing allowance rates from over 70 percent to 
around 40 percent in less than 10 years, therefore crippling 
maintenance fee collection; and,&nbsp;declining applicant morality due to this new&nbsp;found 
rejection mentality, leading to decreased filings. This particular idiot is apparently 
too&nbsp;lazy or 
too stupid to enact any real meaningful change.
</p>
<p>
While 
cutting spending through a&nbsp;hiring freeze, curtailing 
performance awards, and eliminating overtime&nbsp;may provide temporary 
relief, these measures may also drastically increase pendency rates, providing additional disservice to already dissatisfied applicants.
</p>]]>
</content>
</entry>

<entry>
<title>Double Zap</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/06/double_zap.html" />
<modified>2009-06-26T19:59:13Z</modified>
<issued>2009-06-26T19:12:45Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4133</id>
<created>2009-06-26T19:12:45Z</created>
<summary type="text/plain"> Samsung and Sharp have been warring over TV patents at the ITC. Earlier this month, Samsung was found infringing Sharp patents. All the ITC does, or can do, is issue an exclusion order. Now the ITC has determined that Sharp infringes a single Samsung patent. One of the two asserted Samsung patents got tossed. Expect the TVs to stay on store shelves while a cross-license is worked out....</summary>
<author>
<name>Patent Hawk</name>
<url>http://www.patenthawk.com/</url>
<email>info@patenthawk.com</email>
</author>
<dc:subject>ITC</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p>
<img border="0" src="http://www.patenthawk.com/blog_images/tv.gif" align="right" width="96" height="92">Samsung 
and Sharp have been warring over TV patents at the ITC. Earlier this month, 
Samsung was found infringing Sharp patents. All the ITC does, or can do, is 
issue an exclusion order. Now the ITC has determined that Sharp infringes a 
single Samsung patent. One of the two asserted Samsung patents got tossed. Expect the TVs to 
stay on store shelves while a cross-license is worked out.</p>]]>
<![CDATA[<p>For individual inventors, the Supreme Court outlawed injunctive relief in 
2006, in <i>
<a href="http://www.patenthawk.com/blog/2006/05/injunction_mud.html">eBay</a></i>, 
particularly for products with hundreds of patented components. Corporations 
play by different rules.</p>]]>
</content>
</entry>

<entry>
<title>Definitely Not</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/06/definitely_not.html" />
<modified>2009-06-26T19:59:51Z</modified>
<issued>2009-06-26T08:06:11Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4132</id>
<created>2009-06-26T08:06:11Z</created>
<summary type="text/plain"><![CDATA[ Bilski's claims are neither useful nor definite, and hence non-patentable under §101 and §112 ¶2. The Supreme Court should rightfully ignore flawed CAFC case law, looking to its own precedents, most notably Diamond v. Diehr (for §101) and Markman v. Westview Instruments (§112 ¶2). Here's how SCOTUS should shoot down Bilski and claims of its ilk - recognize the intertwining of&nbsp; §101 and §112 ¶2, that an ill-defined process is a strong indicator of indefinite usefulness, and hence unpatentable subject matter....]]></summary>
<author>
<name>Patent Hawk</name>
<url>http://www.patenthawk.com/</url>
<email>info@patenthawk.com</email>
</author>
<dc:subject>§ 101</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p>
<img border="0" src="http://www.patenthawk.com/blog_images/no-brainer.jpg" align="right" width="165" height="150">Bilski's 
claims 
are neither useful nor definite, and hence non-patentable 
under §101 and §112 ¶2. The Supreme Court should rightfully ignore flawed CAFC 
case law, looking to its own precedents, most notably <i>Diamond v. Diehr</i> 
(for §101) and <i>Markman v. Westview Instruments</i> (§112 ¶2). Here's how 
SCOTUS should shoot down <i>Bilski</i> and claims of its ilk - recognize the 
intertwining of&nbsp; §101 and §112 ¶2, that an ill-defined process is a strong 
indicator of indefinite usefulness, and hence unpatentable subject matter.</p>]]>
<![CDATA[<p><b>§101</b></p>
<blockquote>
	<p>35 U.S.C. § 101 Inventions patentable.<br>
	Whoever invents or discovers any new and <u>useful process</u>, machine, 
	manufacture, or composition of matter, or any new and useful improvement 
	thereof, may obtain a patent therefor, subject to the conditions and 
	requirements of this title.</p>
</blockquote>
<p>In a nutshell, the Supreme Court has followed statute in defining the 
boundaries of §101 eligible processes: 1) useful and 2) not abstract. From <i>
<a href="http://www.patenthawk.com/blog/2009/06/the_diamond.html">Diamond v. 
Diehr</a></i>:</p>
<blockquote>
	<p><u>Excluded from such patent protection are laws of nature, natural 
	phenomena, and abstract ideas</u>. <i>See Parker v. Flook</i>, 437 U.S. 584 
	(1978); <i>Gottschalk v. Benson</i>, supra, at 67; <i>Funk Bros. Seed Co. v. 
	Kalo Inoculant Co</i>., 333 U.S. 127, 130 (1948). &quot;An idea of itself is not 
	patentable,&quot; <i>Rubber-Tip Pencil Co. v. Howard</i>, 20 Wall. 498, 507 
	(1874). &quot;A principle, in the abstract, is a fundamental truth; an original 
	cause; a motive; these cannot be patented, as no one can claim in either of 
	them an exclusive right.&quot; <i>Le Roy v. Tatham</i>, 14 How. 156, 175 (1853).
	</p>
</blockquote>
<p>Bilski claim 1:</p>
<blockquote>
	<p>1. A method for <u>managing the consumption risk costs</u> of a commodity 
	sold by a commodity provider at a fixed price comprising the steps of: (a)
	<u>initiating a series of transactions</u> between said commodity provider 
	and consumers of said commodity wherein said consumers purchase said 
	commodity at a fixed rate based upon historical averages, said fixed rate 
	corresponding to a risk position of said consumer; (b) <u>identifying market 
	participants</u> for said commodity having a counter-risk position to said 
	consumers; and (c) <u>initiating a series of transactions</u> between said 
	commodity provider and said market participants at a second fixed rate <u>
	such that </u>said series of market participant transactions <u>balances the 
	risk position </u>of said series of consumer transactions.</p>
</blockquote>
<p>Bilski's process claims three steps: 1) initiate transactions; 2) identify 
market participants; and 3) initiate transactions. Useful? Where is there a 
stated useful result? What about the &quot;such that&quot; clause? It balances risk. Maybe 
useful. Maybe abstract.</p>
<p><b>§112 ¶2</b></p>
<p>Prior to the Patent Act of 1952, the dual prongs of definiteness and 
enablement were in the same sentence. That incurred sometime confusion, though 
clarity shone in <i>
<a href="http://caselaw.lp.findlaw.com/cgi-bin/getcase.pl?court=us&vol=261&invol=45">
Eibel Process Co. v. Minnesota &amp; Ontario Paper Co.</a></i>, 261 U.S. 45 (1923), 
where the Supreme Court related definiteness to usefulness.</p>
<blockquote>
	<p>Indefiniteness is objectionable, because the patent does not disclose to 
	the public how the discovery, if there is one, can be made useful, and how 
	its infringement may be avoided. </p>
</blockquote>
<p>Since 1952...</p>
<blockquote>
	<p>35 U.S.C. 112 Specification.</p>
	<p>¶2 The specification shall conclude with one or more <u>claims 
	particularly pointing out and distinctly claiming the subject matter</u> 
	which the applicant regards as his invention.</p>
</blockquote>
<p>In <i>
<a href="http://caselaw.lp.findlaw.com/scripts/getcase.pl?court=US&vol=517&invol=370">
Markman v. Westview Instruments</a></i>, 517 U.S. 370, 38 USPQ2d 1461 (1996), 
the Supreme Court laid the table for claim construction as the centerpiece of 
patent litigation. On definiteness:</p>
<blockquote>
	<p>It has long been understood&nbsp; that a patent must describe the <u>exact 
	scope of an invention</u> and its manufacture to &quot;secure to [the patentee] all 
	to which he is entitled, [and] to apprise the public of what is still open 
	to them.&quot; <i>McClain v. Ortmayer</i>, 141 U.S. 419, 424 (1891)...</p>
</blockquote>
<p>Whereupon SCOTUS reiterated §112 ¶1&amp;2. The point of definiteness in a patent 
claim is to set boundaries.</p>
<p>Back to <i>Bilski</i>, balancing risk. The claim goes to managing 
&quot;consumption risk&quot; for which Bilski gave an example, not a definition: &quot;e.g., 
the need to use more or less energy than planned due to the weather.&quot; What 
constitutes the cost of consumption risk? What constitutes balance? The scope is 
unclear. Definitely not definite. Hence, not §112 ¶2 compliant. That practically 
proves that the claim goes an &quot;abstract idea.&quot;</p>
<p>The Supreme Court found the CAFC too rigid with its TSM 
(teaching-suggestion-motivation) test for obviousness, but then went overboard 
in grabbing a non-objective yardstick. Many fear that the Supreme Court will 
become even more rigid than the CAFC in <i>Bilski</i>, curtailing or even adding 
more prongs to the CAFC's two-prong process patentability test (1. machine 
dependence; or 2. transformation). But, to get it right, all the Supreme Court 
has to do in <i>Bilski</i> is reaffirm its own precedents, and tighten the loop 
- that a process claim failing &quot;exact scope&quot; demonstrates lack of patentability, 
either in not being clearly useful, or in claiming an abstraction.</p>]]>
</content>
</entry>

<entry>
<title>Paid As Used</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/06/paid_as_used.html" />
<modified>2009-06-25T21:25:50Z</modified>
<issued>2009-06-25T21:23:47Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4131</id>
<created>2009-06-25T21:23:47Z</created>
<summary type="text/plain"><![CDATA[ Richard P. Mettke got 5,602,905, claiming a &quot;public on-line, pay-as-you-use communications terminal.&quot; He wanted his claims directed to the Internet, so he filed for reissue, pursuant to 35 U.S.C. §251, &quot;submitting with his application a declaration stating that he believed the '905 patent to be 'wholly or partly inoperative or invalid by reason of me claiming less than I had the right to claim.'&quot; Naturally, Obzilla stomped on it, with the help of three interested potential infringers slipping the PTO previously uncited art. Not content to have his patent act as a rug, Mettke persisted. The stomping never stopped....]]></summary>
<author>
<name>Patent Hawk</name>
<url>http://www.patenthawk.com/</url>
<email>info@patenthawk.com</email>
</author>
<dc:subject>Prior Art</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p>
<img border="0" src="http://www.patenthawk.com/blog_images/kiosk.jpg" align="right" width="64" height="147">Richard 
P. Mettke got
<a href="http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/PTO/srchnum.htm&r=1&f=G&l=50&s1=5,602,905.PN.&OS=PN/5,602,905&RS=PN/5,602,905">
5,602,905</a>, claiming a &quot;public on-line, pay-as-you-use communications 
terminal.&quot; He wanted his claims directed to the Internet, so he filed for 
reissue, pursuant to
<a href="http://www.uspto.gov/web/offices/pac/mpep/documents/appxl_35_U_S_C_251.htm">
35 U.S.C. §251</a>, &quot;submitting with his application a declaration stating that 
he believed the '905 patent to be 'wholly or partly inoperative or invalid by 
reason of me claiming less than I had the right to claim.'&quot; Naturally, Obzilla 
stomped on it, with the help of three interested potential infringers slipping 
the PTO previously uncited art. Not content to have his patent act as a rug, 
Mettke persisted. The stomping never stopped.</p>]]>
<![CDATA[<p><i><b>In re Richard P. Mettke</b></i> (CAFC
<a href="http://www.cafc.uscourts.gov/opinions/09-1125.pdf">2009-1125</a>) 
non-precedential</p>
<blockquote>
	<p>Richard P. Mettke appeals the decision of the Board of Patent Appeals and 
	Interferences affirming the examiner's rejection of the sole remaining claim 
	(claim 6) in his application for reissue of U.S. Patent No. 5,602,905. Ex 
	parte Mettke, Appeal 2008-0610 (B.P.A.I. Sept. 30, 2008). The Board 
	concluded that claim 6 would have been obvious in light of any of several 
	different combinations of references, and was therefore properly rejected 
	under 35 U.S.C. §103(a).</p>
	<p>Obviousness is a legal conclusion based on underlying findings of fact. 
	In re Thrift, 298 F.3d 1357, 1363 (Fed. Cir. 2002). The factual inquiries 
	relevant to obviousness are set forth in Graham v. John Deere Co., 383 U.S. 
	1, 17-18 (1966), and include (1) the scope and content of the prior art, (2) 
	the differences between the prior art and the claims, (3) the level of 
	ordinary skill in the relevant art, and (4) any objective indicia of 
	non-obviousness such as commercial success, long felt need, and failure of 
	others.</p>
</blockquote>
<p>Mettke apparently hadn't heard the shout of <i>KSR</i>: &quot;A court must ask 
whether the improvement is more than the predictable use of prior art elements 
according to their established functions.&quot;</p>
<blockquote>
	<p>Mr. Mettke criticizes the Board's finding that the field of endeavor is 
	"pay-for-use public communication terminals," arguing that this field was 
	too broad and led the Board to consider non-analogous art.</p>
</blockquote>
<p>But the prior art was analogous, even as four references were used for 
invalidation. The capper was &quot;article by Rawn Shah titled '<i>Suggestions for 
Information Kiosk Systems using the World Wide Web</i>.'&quot;</p>
<blockquote>
	<p>The Board found that the Shah reference teaches the addition of the sole 
	remaining element: "means for accessing the Internet." Shah describes "a 
	kiosk based information system using the World Wide Web on the Internet as 
	an interface."</p>
</blockquote>
<p>Mettke, delusional, argued otherwise.</p>
<blockquote>
	<p>Mr. Mettke argues, as he did before the Board, that the Shah reference 
	does not disclose "accessing the Internet" at all. He contends that the PTO 
	"grossly misinterpret[ed] the Shah prior art," and that Shah "teaches away 
	from accessing the Internet." Petr.'s Br. 6. He contends that Shah's 
	discussion of the World Wide Web is limited to the use of a Web "browser" to 
	access only limited information on a "standalone network," meaning one that 
	is not connected to the larger Internet. The Board considered these 
	contentions, and rejected them based on the text of the Shah reference, 
	finding that Shah plainly discloses an information kiosk that uses the 
	"World Wide Web on the Internet as an interface." Board op. at 22 (quoting 
	Shah, abstract). Shah mentions access to the Internet expressly and 
	repeatedly, as the Board explained. Substantial evidence supports the 
	Board's reading of the content of the Shah reference and its application, as 
	analogous art, to claim 6.</p>
</blockquote>
<p>Mettke got a response about hindsight, but not the one hoped for.</p>
<blockquote>
	<p>Mr. Mettke contends the Board engaged in hindsight analysis, using his 
	patent as a blueprint for the combination of elements from various sources. 
	Mr. Mettke is correct that the selective hindsight combination of references 
	that show various elements of the claim generally does not suffice to 
	establish obviousness. <i>See KSR Int'l Co. v. Teleflex In</i>c., 550 U.S. 
	398, 418 (2007) ("[A] patent composed of several elements is not proved 
	obvious merely by demonstrating that each of its elements was, 
	independently, known in the prior art.").</p>
	<p>But the Board's analysis included more than a combination of disparate 
	references disclosing different elements, for the Board explained why Shah 
	teaches the very combination of elements that Mr. Mettke sought to claim. 
	The Board found that Shah does not merely disclose "accessing the Internet" 
	as a general matter; Shah expressly teaches Internet access in connection 
	with information and communication kiosks--the kinds of public communication 
	terminals described in Exhibits E and F. Shah provides explicit support for 
	the Board's finding that a person of ordinary skill would have been 
	motivated to modify existing information kiosks or terminals to provide 
	access to the Internet.</p>
</blockquote>
<p>The final cup of weak tea was arguing non-obviousness because of commercial 
success.</p>
<blockquote>
	<p>Mr. Mettke also states that "over 50% of all [now-existing] kiosks have 
	all of the elements" of claim 6, suggesting commercial success. The Board 
	found that Mr. Mettke failed to establish a "nexus" between this asserted 
	wide use and his invention. <i>See In re Paulsen</i>, 30 F.3d 1475, 1482 
	(Fed. Cir. 1994) ("When a patentee offers objective evidence of 
	nonobviousness, there must be a sufficient relationship between that 
	evidence and the patented invention."). We note that when the commercially 
	successful device is the claimed invention itself, there is a presumption of 
	nexus. <i>See Demaco Corp. v. F. Von Langsdorff Licensing Ltd.</i>, 851 F.2d 
	1387, 1392 (Fed. Cir. 1988). However, the Board found that Mr. Mettke failed 
	to meet his burden because he has not shown that the alleged commercial 
	success is due to the claimed invention. We conclude that the evidence of 
	obviousness was not, in this case, rebutted by the asserted commercial 
	success.</p>
</blockquote>
<p>Affirmed.</p>]]>
</content>
</entry>

<entry>
<title>Mastered</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/06/mastered.html" />
<modified>2009-06-25T04:49:08Z</modified>
<issued>2009-06-25T04:47:28Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4130</id>
<created>2009-06-25T04:47:28Z</created>
<summary type="text/plain"> Peter Hochstein and Jeffrey Tenenbaum scored one against Microsoft in their Xbox patent match, ongoing since 2004. East Michigan Judge Paul D. Borman has adopted a critical claim construction determined by his special master in the case. Claim 39 of 5,292,125 involves a communication circuit. Microsoft wanted a non-infringement knockout, construing the circuit within a particular configuration which it does not employ. The special master didn&apos;t find any such narrowing limitation in the claim. Looks like this one is going down to the wire, with Microsoft outboxed....</summary>
<author>
<name>Patent Hawk</name>
<url>http://www.patenthawk.com/</url>
<email>info@patenthawk.com</email>
</author>
<dc:subject>Claim Construction</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p>
<img border="0" src="http://www.patenthawk.com/blog_images/xbox.gif" align="right" width="80" height="89">Peter 
Hochstein and Jeffrey Tenenbaum scored one against Microsoft in their
<a href="http://www.patenthawk.com/blog/2009/05/typo.html">Xbox patent match</a>, 
ongoing since 2004. East Michigan Judge Paul D. Borman has adopted a critical 
claim construction determined by his special master in the case. Claim 39 of
<a href="http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/PTO/srchnum.htm&r=1&f=G&l=50&s1=5,292,125.PN.&OS=PN/5,292,125&RS=PN/5,292,125">
5,292,125</a> involves a communication circuit. Microsoft wanted a 
non-infringement knockout, construing the circuit within a particular 
configuration which it does not employ. The special master didn't find any such 
narrowing limitation in the claim. Looks like this one is going down to the 
wire, with Microsoft outboxed.</p>]]>

</content>
</entry>

<entry>
<title>Unappealing</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/06/unappealing.html" />
<modified>2009-06-23T23:28:26Z</modified>
<issued>2009-06-23T23:25:36Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4129</id>
<created>2009-06-23T23:25:36Z</created>
<summary type="text/plain"><![CDATA[ More than ever, patent prosecution is a gambler's game. As Admiral Adama in Battlestar Galactica observes: &quot;sometimes you have to roll the hard six.&quot; In prosecution, facing an objectionable rejection, appeal. Professor Dennis D. Crouch has taken a cold-eyed look at rejection rates for BPAI appeals. Not a savory prospect. The hard six is a very hard roll, particularly when playing against Obzilla....]]></summary>
<author>
<name>Patent Hawk</name>
<url>http://www.patenthawk.com/</url>
<email>info@patenthawk.com</email>
</author>
<dc:subject>Prosecution</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p>
<img border="0" src="http://www.patenthawk.com/blog_images/dice7.jpg" align="right" width="115" height="72">More 
than ever, patent prosecution is a gambler's game. As Admiral Adama in
<a href="http://www.scifi.com/battlestar/home.html">Battlestar Galactica</a> 
observes: &quot;sometimes you have to roll the hard six.&quot; In prosecution, facing an 
objectionable rejection, appeal. Professor Dennis D. Crouch has taken a 
cold-eyed look at
<a href="http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1423922">rejection 
rates for BPAI appeals</a>. Not a savory prospect. The hard six is a very hard 
roll, particularly when playing against Obzilla.</p>]]>
<![CDATA[<p>The rejection regime of the past few years has resulted in an appeal-all 
kickback from prosecutors. That regime is taking its toll on the BPAI. The 
number of appeals is expected to double in 2009 from 2008, to a record 6,400. 
Professor Crouch attributes &quot;two factors have led to this short term dramatic 
rise in appeals: (1) an increase in rejection rate by patent examiners; and (2) 
attempts by the PTO to limit non-appeal avenues for achieving full claim scope.&quot;</p>
<p>Professor Crouch:</p>
<blockquote>
	<p>Most appeals from examiner rejections focus on two or more issues. [2.1 
	issues was the average.] Of those, the majority of rejections (61%) are 
	affirmed and the remainder reversed. When more issues are presented, the 
	case as a whole becomes more likely to be affirmed-in-part.</p>
	<p>87% - 90% of cases decided an issue of obviousness. Only 4% of appeals 
	consider neither obviousness nor novelty.</p>
	<p>The Board is authorized to offer new grounds for rejection, and did so in 
	about 4% of the cases in the hand-scored study. The most common new ground 
	was for obviousness.</p>
	<p>More than half of the appeal decisions (54%) focused solely on 
	obviousness. The closest runner-up issue - anticipation - was an issue in 
	37% of the appeals. Other issues on appeal (each with a frequency of &lt; 5%) 
	included in descending frequency: written description requirement; 
	indefiniteness, patentable subject matter, obviousness-type double 
	patenting, and enablement.</p>
	<p>The fact that the majority of issues involve obviousness spells trouble 
	for applicants.</p>
</blockquote>
<p>Biotechnology and organic chemistry (TC 1600) are an outlier: 18% of those 
BPAI decisions are focused on issues other than prior art.</p>
<p>The non-objective standard of
<a href="http://www.patenthawk.com/blog/2007/04/obviousness_redux.html"><i>KSR</i></a> 
renders obviousness a pandemic killer. Otherwise, an examiner is far more often 
found wrong than right, a figure that indicates general examiner incompetence, 
for sticking with rejections that are not well-founded.</p>
<blockquote>
	<p>Obviousness rejections are more likely to be affirmed than are other 
	types of rejections. Cases that discuss neither obviousness nor novelty are 
	reversed in 74% of cases.</p>
</blockquote>
<p>
<img border="0" src="http://www.patenthawk.com/blog_images/crouch_bpai_t1.jpg" align="right" width="497" height="208">The 
outcome upshot is shown by Table 1. &quot;10% of cases that were affirmed included 
one or more individual issues that were reversed.&quot; This occurred where an 
examiner piled on the rejections, both anticipated &amp; obvious over multiple prior 
art references, and while reversing the most outlandish rejection, the Board 
need only agree with the examiner on one issue to down the application.</p>
<p>In the case of multiple issues, the BPAI tends to split the baby from the 
bathwater. &quot;As more issues are presented, the likelihood of a split decision 
(affirmed-in-part) rises dramatically while the likelihood of the case being 
completely affirmed or completely reversed drops.&quot;</p>
<p>The good Professor points out that examiner error on rejected claims is but a 
partial story. The other side of the examiner error coin is allowing claims that 
should not have been. That appeal is more often than not heard in the 
courthouse.</p>]]>
</content>
</entry>

<entry>
<title>Compatible</title>
<link rel="alternate" type="text/html" href="http://www.patenthawk.com/blog/2009/06/compatible.html" />
<modified>2009-06-22T18:13:48Z</modified>
<issued>2009-06-22T18:12:09Z</issued>
<id>tag:www.patenthawk.com,2009:/blog//1.4128</id>
<created>2009-06-22T18:12:09Z</created>
<summary type="text/plain"><![CDATA[ &quot;We are revising all the doctrines and laws related to patents, which should be compatible with the international treaties that we have signed and respect and honor. Patents have become a barrier to production, and we cannot allow them to be barriers to medicine, to life, to agriculture.&quot; Sounds like the Coalition for Patent Fairness, doesn't it? Venezuela is stealing their shtick. South American socialist Hugo Chavez plies his pith: &quot;That a laboratory does not allow us to make a medicine because they have the patent, no, no, no.&quot;...]]></summary>
<author>
<name>Patent Hawk</name>
<url>http://www.patenthawk.com/</url>
<email>info@patenthawk.com</email>
</author>
<dc:subject>International</dc:subject>
<content type="text/html" mode="escaped" xml:lang="en" xml:base="http://www.patenthawk.com/blog/">
<![CDATA[<p>
<img border="0" src="http://www.patenthawk.com/blog_images/hugo_chavez.jpg" align="right" width="117" height="129">&quot;We 
are revising all the doctrines and laws related to patents, which should be 
compatible with the international treaties that we have signed and respect and 
honor. Patents have become a barrier to production, and we cannot allow them to 
be barriers to medicine, to life, to agriculture.&quot; Sounds like the
<a href="http://www.patentfairness.org/">Coalition for Patent Fairness</a>, 
doesn't it? Venezuela is stealing their shtick. South American socialist Hugo 
Chavez plies his pith: &quot;That a laboratory does not allow us to make a medicine 
because they have the patent, no, no, no.&quot;</p>]]>
<![CDATA[<p><a href="http://www.reuters.com/article/marketsNews/idUSN2148323120090621">
Reuter</a>:</p>
<blockquote>
	<p>Chavez, who has nationalized many Venezuela industries and is critical of 
	the private sector, ordered his trade minister to analyze the patent rules 
	in the OPEC nation.</p>
</blockquote>
<p>
<a href="http://www.google.com/hostednews/ap/article/ALeqM5i9kFmvG7bl1pq4nm8sgZUfk84KZQD98VALE01">
AP</a>: </p>
<blockquote>
	<p>Venezuelan officials plan to invalidate some pharmaceutical patents and 
	allow domestic manufacturers to produce licensed medicines, an action that 
	could cause shortages and scare off foreign investment, industry leaders 
	said Sunday.</p>
</blockquote>
<p>Chavez also called &quot;on the world to respect Iran&quot; and the election &quot;triumph&quot; 
of its incumbent president, Mahmoud Ahmadinejad. &quot;Ahmadinejad's triumph was a 
triumph all the way.&quot;</p>]]>
</content>
</entry>

</feed>